These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1708454)

  • 1. Immunohistochemical detection and correlation between MHC antigen and cell-mediated immune system in recurrent glioma by APAAP method.
    Miyagi K; Ingram M; Techy GB; Jacques DB; Freshwater DB; Sheldon H
    Neurol Med Chir (Tokyo); 1990 Sep; 30(9):649-55. PubMed ID: 1708454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.
    Saito T; Tanaka R; Yoshida S; Washiyama K; Kumanishi T
    Surg Neurol; 1988 Jun; 29(6):435-42. PubMed ID: 3259730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local immunotherapy with OK-432 for malignant gliomas--immunohistochemical analysis of chronological changes of tumor tissues].
    Saito T; Tanaka R; Sekiguchi K; Yoshida S; Washiyama K; Yamada N; Takeda N
    No To Shinkei; 1988 Jul; 40(7):609-15. PubMed ID: 3224036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma.
    Morioka T; Baba T; Black KL; Streit WJ
    Acta Neuropathol; 1992; 83(6):590-7. PubMed ID: 1636377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
    van Houdt IS; Sluijter BJ; Moesbergen LM; Vos WM; de Gruijl TD; Molenkamp BG; van den Eertwegh AJ; Hooijberg E; van Leeuwen PA; Meijer CJ; Oudejans JJ
    Int J Cancer; 2008 Aug; 123(3):609-15. PubMed ID: 18498132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNγ enhances cytotoxic efficiency of the cytotoxic T lymphocytes against human glioma cells.
    Shao S; Risch E; Burner D; Lu L; Minev B; Ma W
    Int Immunopharmacol; 2017 Jun; 47():159-165. PubMed ID: 28410529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
    Tsuboi A; Hashimoto N; Fujiki F; Morimoto S; Kagawa N; Nakajima H; Hosen N; Nishida S; Nakata J; Morita S; Sakamoto J; Oji Y; Oka Y; Sugiyama H
    Cancer Immunol Immunother; 2019 Feb; 68(2):331-340. PubMed ID: 30430205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of MHC class-1 antigen on rat glioma cells to cytokines.
    Oshiro S; Fukushima T; Tomonaga M; Black KL
    Anticancer Res; 2000; 20(1C):605-10. PubMed ID: 10769703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
    Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
    No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
    Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
    Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas.
    Saito T; Tanaka R; Kouno M; Washiyama K; Abe S; Kumanishi T
    J Neurosurg; 1989 Jan; 70(1):81-5. PubMed ID: 2909691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
    Matsuhisa T
    No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
    J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
    Park IA; Hwang SH; Song IH; Heo SH; Kim YA; Bang WS; Park HS; Lee M; Gong G; Lee HJ
    PLoS One; 2017; 12(8):e0182786. PubMed ID: 28817603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.
    Wikstrand CJ; Grahmann FC; McComb RD; Bigner DD
    J Neuropathol Exp Neurol; 1985 May; 44(3):229-41. PubMed ID: 2580959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of brain tumors.
    Sawamura Y; De Tribolet N
    J Neurosurg Sci; 1990; 34(3-4):265-78. PubMed ID: 2098505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma.
    Tamori Y; Tan X; Nakagawa K; Takai E; Akagi J; Kageshita T; Egami H; Ogawa M
    Oncol Rep; 2005 Oct; 14(4):873-7. PubMed ID: 16142345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.